I have other low priced stocks on the NASDAQ that are marginable, TRIBY isn't. The company is profitable, and seems to be heading up in price. Is this a function of it being a foreign security, or being on the "small cap" portion of NASDAQ. Any thoughts?
P.S. I think patience here will be nicely rewarded, though the company is clearly not a bio-tech (and probably not a pharmaceutical either)